Susquehanna International Group’s Terns Pharmaceuticals TERN Stock Holding History

Susquehanna International Group’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$31.5M	Buy	597,300 +531,100	+802%	+$21.8M	﹤0.01%	1686
2025 Q4	$2.67M	Buy	66,200 +53,100	+405%	+$1.23M	﹤0.01%	5087
2025 Q3	$98.4K	Buy	+13,100	New	+$83.6K	﹤0.01%	11575
2025 Q1	–	Sell	-43,400	Closed	-$240K	–	13449
2024 Q4	$240K	Sell	43,400 -126,700	-74%	-$858K	﹤0.01%	10299
2024 Q3	$1.42M	Buy	170,100 +89,400	+111%	+$736K	﹤0.01%	6031
2024 Q2	$550K	Buy	80,700 +51,600	+177%	+$313K	﹤0.01%	8044
2024 Q1	$191K	Buy	29,100 +6,400	+28%	+$41.8K	﹤0.01%	10640
2023 Q4	$147K	Buy	+22,700	New	+$120K	﹤0.01%	10993
2023 Q3	–	Sell	-92,000	Closed	-$805K	–	12967
2023 Q2	$805K	Buy	+92,000	New	+$1.07M	﹤0.01%	7185

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Susquehanna International Group's TERN Position: Q1 2026 in Review

Susquehanna International Group increased its Terns Pharmaceuticals (TERN) stake by 6,765% in Q1 2026, buying an estimated $21.1M and bringing the position to 521,571 shares worth $27.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Susquehanna International Group first reported a position in TERN in Q4 2022 and has held it in 13 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Susquehanna International Group held 521,571 shares of Terns Pharmaceuticals worth $27.5M as of Q1 2026.
Susquehanna International Group bought 513,974 Terns Pharmaceuticals shares in Q1 2026, an estimated $21.1M.
Terns Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1844 holding.
Susquehanna International Group first reported a position in Terns Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.